ARID5B and acute lymphoblastic leukemia: Our data are compatible with the rs7090445-C allele conferring increased HD-ALL risk through reduced RUNX3-mediated expression of ARID5B. CRISPR/Cas9 genome editing of rs7090445 should provide further support for these assertions, given the limitations of luciferase-based assays.